Abstract：Currently, the value of adjuvant therapy after radical resection of esophageal squamous cell carcinoma remains elusive. Some studies have reported that radiotherapy can improve the locoregional control rate and overall survival of patients. However, the design of radiotherapy target area, intervention time and dose of radiotherapy are controversial. In this article, literature review was conducted and the current status and controversy of adjuvant radiotherapy after radical resection of esophageal squamous cell carcinoma were reviewed.
Li Bingxu,Wang Kunlun,Yang Hui et al. Current status and controversy of adjuvant radiotherapy after radical resection of esophageal squamous cell carcinoma[J]. Chinese Journal of Radiation Oncology, 2020, 29(11): 1017-1020.
[1] Teniere P, Hay JM, Fingerhut A, et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research[J]. Surg Gynecol Obstet, 1991, 173(2):123-130. [2] Zieren HU, Muller JM, Jacobi CA, et al. Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus:A prospective randomized study[J]. World J Surg, 1995, 19(3):444-449. DOI:10.1007/BF00299187. [3] 梅泽如,项其昌,吴维继,等. 食管癌术后预防性放疗前瞻性研究[J]. 中华放射肿瘤学杂志, 1997, 6(3):54-55. Mei ZR, Xiang QC, Wu WJ, et al. Prospective study on postoperative prophylactic radiotherapy for esophageal cancer[J]. Chin J Radiat Oncol, 1997, 6(3):54-55. [4] Xiao ZF, Yang ZY, Liang J, et al. Value of radiotherapy after radical surgery for esophageal carcinoma:a report of 495 patients[J]. Ann Thorac Surg, 2003, 75(2):331-336. DOI:10.1007/BF00299187. [5] Xiao ZF, Yang ZY, Miao YJ, et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy:report of 549 cases[J]. Int J Radiat Oncol Biol Phys, 2005, 62(1):82-90. DOI:10.1016/j.ijrobp.2004.08.046. [6] Chen J, Zhu J, Pan J, et al. Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus[J]. Ann Thorac Surg, 2010, 90(2):435-442. DOI:10.1016/j.athoracsur.2010.04.002. [7] Chen S, Weng H, Wang G, et al. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma[J]. J Canc Res Clin Oncol, 2016, 142(1):277-286. DOI:10.1007/s00432-015-2041-z. [8] Yu S, Zhang W, Ni W, et al. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage Ⅲ esophageal squamous cell carcinoma after R0 esophagectomy[J]. Radiother Oncol, 2019, 140:159-166. DOI:10.1016/j.radonc.2019.06.020. [9] Wang S, Wang Z, Yang Z, et al. Postoperative radiotherapy improves survival in stage pT2N0M0esophageal squamous cell carcinoma with high risk of poor prognosis[J]. Ann Surg Oncol, 2016, 23(1):265-272. DOI:10.1245/s10434-015-4622-0. [10] Yang J, Zhang W, Xiao Z, et al. The impact of postoperative conformal radiotherapy after radical surgery on survival and recurrence in pathologicT3N0M0esophageal carcinoma:a propensity score-matched analysis[J]. J Thorac Oncol, 2017, 12(7):1143-1151. DOI:10.1016/j.jtho.2017.03.024. [11] Deng W, Yang JS, Ni WJ, et al. Postoperative radiotherapy in pathologicalT2-3N0M0thoracic esophageal squamous cell carcinoma:interim report of a prospective, phase Ⅲ, randomized controlled study[J]. Oncologist, 2020, 25(4):e701-e708. DOI:10.1634/theoncologist.2019-0276. [12] Lordick F, Mariette C, Haustermans K, et al. Oesophageal cancer:ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2016, 27(1):v50-v57. DOI:10.1093/annonc/mdw329. [13] Kitagawa Y, Uno T, Oyama T, et al. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society:part 1[J]. Esophagus, 2019, 16(1):1-24. DOI:10.1007/s10388-018-0641-9. [14] 国家卫生健康委员会. 食管癌诊疗规范(2018年版)[J]. 中华消化病与影像杂志(电子版), 2019, 9(4). DOI:10.3877/cma.j.issn.2095-2015.2019.04.005. National Health Commission. Guidelines for the diagnosis and treatment of esophageal cancer (2018 edition)[J]. Chin J Digest Med Imageol (Elect ed), 2019, 9(4). DOI:10.3877/cma.j.issn.2095-2015.2019.04.005. [15] Yamada S, Takai Y, Nemoto K, et al. Prognostic impact of the period between surgery and postoperative irradiation in esophageal carcinoma[J]. Tohoku J Expe Med, 1994, 172(3):275-282. DOI:10.1620/tjem.172.275. [16] 马雷. 食管癌根治术后放射治疗的长期生存预后影响因素及其治疗失败模式分析[D]. 石家庄:河北医科大学, 2013. Ma L. The long-term survival prognostic influence factors of prophylactic postoperative radiotherapy for esophageal cancer and its failure mode analysis[D]. Shijiazhuang:Hebei Medical University, 2013. [17] Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus[J]. Ann Surg, 1994, 220(3):364-373. DOI:10.1097/00000658-199409000-00012. [18] 安丰山,黄金球,陈少湖,等. 217例胸段食管癌淋巴结转移及其对预后影响的分析[J]. 癌症, 2003, 22(9):974-977. DOI:10.3969/j.issn.1000-467X.2003.09.016. An FS, Huang JQ, Chen SH, et al. Analysis of lymph node metastases of 217 cases of thoracic esophageal carcinoma and its impact on prognosis[J]. Chin J Canc, 2003, 22(9):974-977. DOI:10.3969/j.issn.1000-467X.2003.09.016. [19] 王永岗,汪良骏,张德超,等. 胸段食管鳞癌淋巴结转移特点及临床意义[J]. 中华肿瘤杂志, 2000, 22(3):241-243. DOI:10.3760/j.issn:0253-3766.2000.03.025. Wang YG, Wang LJ, Zhang DC, et al. Characteristics of lymph node metastasis of squamous cell carcinoma of thoracic esophagus and its clinical significance[J]. Chin J Oncol, 2000, 22(3):241-243. DOI:10.3760/j.issn:0253-3766.2000.03.025. [20] Cai W, Xin P. Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy[J]. Radiother Oncol, 2010, 96(1):104-107. DOI:10.1016/j.radonc.2010.04.029. [21] Li C, Zhang F, Wang Y, et al. Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer[J]. Oncol Lett, 2013, 5(1):355-359. DOI:10.3892/ol.2012.946. [22] Su X, Zhang DK, Zhang X, et al. Prognostic factors in patients with recurrence after complete resection of esophageal squamous cell carcinoma[J]. J Thorac Dis, 2014, 6(7):949-957. DOI:10.3978/j.issn.2072-1439.2014.07.14. [23] Liu J, Cai X, Liu Q, et al. Characteristics of the local recurrence pattern after curative resection and values in target region delineation in postoperative radiotherapy for lower thoracic esophageal squamous cell cancer[J]. Thorac Canc, 2017, 8(6):630-633. DOI:10.1111/1759-7714.12499. [24] Ni WJ, Yang JS, Deng W, et al. Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinoma[J]. BMC Canc, 2020, 20(1):144. DOI:10.1186/s12885-020-6622-0. [25] 李建成, 许之晨, 潘建基, 等. 食管癌术后放疗与未放疗局部复发的比较[J]. 中国癌症防治杂志, 2012, 4(4):331-335. DOI:1674-5671(2012) 04-05. Li JC, Xu ZC, Pan JJ, et al. Comparison of local recurrence patterns of esophageal carcinoma after surgery with and without postoperative radiotherapy[J]. Chin J of Oncol Prev and Treat, 2012, 4(4):331-335. DOI:1674-5671(2012) 04-05. [26] Chen J, Pan J, Zheng X, et al. Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2012, 82(1):475-482. DOI:10.1016/j.ijrobp.2010.08.037. [27] Qiao XY, Wang W, Zhou Z, et al. Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma[J]. Int J Radiat Oncol Biol Phys, 2007, 70(2):396-402. DOI:10.1016/j.ijrobp.2007.06.031. [28] Lu JC, Tao H, Zhang YQ, et al. Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma[J]. Dis Esophagus, 2008, 21(6):502-507. DOI:10.1111/j.1442-2050.2007.00797.x. [29] Zhang XF, Yang X, Ni JJ, et al. Recommendation for the definition of postoperative radiotherapy target volume based on a pooled analysis of patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma[J]. Radiat Oncol (London, England), 2018, 13(1):255. DOI:10.1186/s13014-018-1199-3. [30] 何健,赵快乐,曾昭冲,等. 食管癌局部小野术后放疗的疗效分析[J]. 复旦学报(医学版), 2002, 29(5):390-392. DOI:10.3969/j.issn.1672-8467.2002.05.017. He J, Zhao KL, Zeng ZC, et al. Clinical ananysis of postoperative radiotherapy with local fields in the patient with esophageal cancer[J]. Fudan Univ J Med Sci, 2002, 29(5):390-392. DOI:10.3969/j.issn.1672-8467.2002.05.017. [31] 吴凤鹏, 张明, 张海娟, 等. 食管鳞癌术后复发因素的Logistic回归分析[J]. 肿瘤防治研究, 2010, 37(1):56-59. DOI:1000-8578(2010) 01-0056-04. Wu FP, Zhang M, Zhang HJ, et al. Logistic regression analysis of factors influencing for postop recurrence of esophageal squamous carcinoma[J]. Canc Res Prevent Treat, 2010, 37(1):56-59. DOI:1000-8578(2010) 01-0056-04. [32] 张新良, 张道富, 王晓萍, 等. 胸段食管癌术后预防照射三维适形放疗与常规放疗剂量学比较[J]. 临床肿瘤学杂志, 2008, 13(5):421-423. DOI:10.3969/j.issn.1009-0460.2008.05.009. Zhang XL, Zhang DF, Wang XP, et al. Comparison of dose distribution between 3-DCRT and conventional radiotherapy in postoperative radiotherapy for thoracic esophageal carcinoma[J]. Chin Clin Oncol, 2008, 13(5):421-423. DOI:10.3969/j.issn.1009-0460.2008.05.009.
2020, Vol. 29 
